Evidence map›Paper›PMID 22850252›Full record

ReviewChimerism

Bidirectional alloreactivity: A proposed microchimerism-based solution to the NIMA paradox.

William J Burlingham, Gilles Benichou

Abstract readReview
In one paragraph

Review in Chimerism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Maternal microchimerism and cell-mediated immune-modulation enhance engraftment following semi-allogenic intrauterine transplantation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  2. Review
  3. Maintaining T cell tolerance of alloantigens: Lessons from animal studies.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2018
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

William J BurlinghamDepartment of Surgery, University of Wisconsin, Madison, WI, USA. burlingham@surgery.wisc.edu
Gilles Benichou

Funding

Maternal Microchimerism and Neonatal ToleranceR01AI066219 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI BURLINGHAM, WILLIAM J · 2006 to 2016
$3.3M
Effects of Lymphangiogenesis Blockade on Skin Allograft RejectionR21AI100278 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BENICHOU, GILLES A · 2012 to 2013
$370k
NIAID NIH HHS R01 AI066219NIAID NIH HHS R21 AI100278
6 · The paper itself

Abstract

The NIMA paradox is the observation that in transplants of allogeneic kidneys or hematopoietic stem cells, siblings benefit from re-exposure to non-inherited maternal antigens (NIMA), whereas re-exposure to a transplant from mother herself, theoretically the ideal "NIMA" donor, does not yield clinical results superior to a father-donated allograft. Recent observations of bidirectional alloreactivity in kidney and cord blood transplantation offer a possible solution to this paradox. If correct, the proposed solution points the way to clinical applications of microchimerism in solid organ and hematopoetic transplants.

Indexed as

ChimerismAnimalsCord Blood Stem Cell TransplantationGraft vs Host DiseaseHumansImmune ToleranceIsoantigensKidney TransplantationTransplantation, HomologousTransplantation ToleranceIsoantigens

Identifiers

PMID22850252
PMCPMC3442809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.